Published

Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 2026-02-13
Source: Europe PMC
DOI: 10.1002/snz2.70002
PubMed: 41798779

Authors

McNaughton N Shadli SM Beaglehole B Glue P.

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD OCD Brain Imaging Mechanism of Action Biomarkers Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility studyPhilosophical Transactions of the Royal Society B Biological Sciences · 2024-10-20 Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways ForwardAction Research · 2026-02-28 Escitalopram/psilocybinReactions Weekly · 2025-06-12 AEs reported after use of psychedelics such as psilocybinReactions Weekly · 2024-09-20 Chlorothiazide/paracetamol/psilocybinReactions Weekly · 2022-11-10 Confusion over psilocybin toxicityReactions · 1982-07-31 Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C12 H17 N2 O4 PJournal of the Chemical Society Perkin Transactions 2 · 1973-12-31 Occurrence of psilocybin in the sporophores of Psilocybe semilanceataTransactions of the British Mycological Society · 1969-09-30